Ulcer of esophagus without bleeding
Methodology & AI Transparency ⓘ
Ulcer of esophagus without bleeding Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Physicians managing Ulcer of esophagus without bleeding (K22.10; Acid Reflux, GERD & Upper GI Health) utilize alarm-symptom upper endoscopy in Ulcer of esophagus without bleeding (K22.10: (EGD) triage) and objective H.
- 2 Real-world patient consensus: Mapped to Acid Reflux, GERD & Upper GI Health under ICD-10-CM K22.10 for Ulcer of esophagus without bleeding clinical workups.
- 3 Typical cash cost range: Clinicians assessing Ulcer of esophagus without bleeding focus on transient lower esophageal in Ulcer of esophagus without bleeding (K22.10: sphincter relaxation) and targeted history.
- 4 Top reported side effects / signs: Objective lab/clinical target for Ulcer of esophagus without bleeding: H. pylori Stool in Ulcer of esophagus without bleeding (K22.10: Antigen or Urea) (Negative (K22.10)) and Hemoglobin & Serum in Ulcer of esophagus without bleeding (K22.10: Ferritin).
Ask our AI Specialists anything about Ulcer of esophagus without bleeding
What Is Ulcer of esophagus without bleeding?
Physicians managing Ulcer of esophagus without bleeding (K22.10; Acid Reflux, GERD & Upper GI Health) utilize alarm-symptom upper endoscopy in Ulcer of esophagus without bleeding (K22.10: (EGD) triage) and objective H. pylori Stool in Ulcer of esophagus without bleeding (K22.10: Antigen or Urea) targets (Negative (K22.10)) to prevent progression and functional morbidity.
Pathophysiology, Underlying Causes & Clinical Presentation
Pathophysiologically, Ulcer of esophagus without bleeding (ICD-10 K22.10) is driven by transient lower esophageal in Ulcer of esophagus without bleeding (K22.10: sphincter relaxation); specialists in Acid Reflux, GERD & Upper GI Health monitor Hemoglobin & Serum in Ulcer of esophagus without bleeding (K22.10: Ferritin) to gauge tissue recovery.
Common Symptoms & Clinical Signs
- • Presentation of Ulcer of esophagus without bleeding (K22.10): chronic throat clearing, in Ulcer of esophagus without bleeding (K22.10: hoarseness, nocturnal cough,)
- • Secondary Ulcer of esophagus without bleeding clinical sign: nausea, belching, or in Ulcer of esophagus without bleeding (K22.10: discomfort relieved or)
- • Symptom flares in Ulcer of esophagus without bleeding correlating with H. pylori Stool in Ulcer of esophagus without bleeding (K22.10: Antigen or Urea) deviation outside Negative (K22.10)
- • Functional gerd & stomach impact requiring alarm-symptom upper endoscopy in Ulcer of esophagus without bleeding (K22.10: (EGD) triage) evaluation (K22.10)
Ulcer of esophagus without bleeding Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | K22.10 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Acid Reflux, GERD & Upper GI Health | NLM Clinical Tables |
| Diagnostic / Lab Marker: H. pylori Stool in Ulcer of esophagus without bleeding (K22.10: Antigen or Urea) | Negative (K22.10) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Hemoglobin & Serum in Ulcer of esophagus without bleeding (K22.10: Ferritin) | Ferritin > 50 ng/mL (no occult loss) (K22.10) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Vitamin B12 in Ulcer of esophagus without bleeding (K22.10: & Magnesium (chronic) | B12 > 450 pg/mL; Mg >= 2.0 mg/dL (K22.10) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Ulcer of esophagus without bleeding
Treatment selection for Ulcer of esophagus without bleeding depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Ulcer of esophagus without bleeding)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Benefits and safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor: What a 1,139-Participant Study Found Tofacitinib was efficacious in patients with UC regardless of prior TNFi failure status. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association • 2022-03-15 • Phase III Randomized Trial | N = 1,139 | 96/100 | PMID 33684552 ↗ |
| New Insights on Vonoprazan non-inferior to lansoprazole in treating duodenal ulcer and: What a 263-Participant Study Found Vonoprazan was well tolerated and non-inferior to lansoprazole for duodenal ulcer healing and achieved H. Journal of gastroenterology and hepatology • 2022-07-15 • Phase III Randomized Trial | N = 263 | 93/100 | PMID 35342997 ↗ |
| New Insights on Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events: What a 787-Participant Study Found Patients receiving etrasimod demonstrated no increased risk of infection. Journal of Crohn's & colitis • 2024-10-15 • Phase III Randomized Trial | N = 787 | 93/100 | PMID 38700040 ↗ |
| New Insights on Effect and safety of anaprazole in the treatment of duodenal ulcers: a: What a 448-Participant Study Found The efficacy of anaprazole is non-inferior to that of rabeprazole in Chinese patients with duodenal ulcers. Chinese medical journal • 2022-12-20 • Phase III Randomized Trial | N = 448 | 93/100 | PMID 36580650 ↗ |
| New Insights on Long-term safety and real-world benefits of filgotinib for the treatment of: What a 250-Participant Study Found Filgotinib induced and maintained symptomatic full symptom relief and improved HRQoL over 4 years. Alimentary pharmacology & therapeutics • 2024-09-15 • Phase III Randomized Trial | N = 250 | 93/100 | PMID 39086130 ↗ |
Ulcer of esophagus without bleeding Patient Community & “People Like Me” Threads
Filter Ulcer of esophagus without bleeding community threads and patient logs by age, biological sex, dosage, and treatment duration.